The new multidisciplinary paradigm for fatty liver disease should also include the laboratory medicine contribution

Liver Int. 2021 Aug;41(8):1981-1982. doi: 10.1111/liv.14987. Epub 2021 Jul 4.

Author

Mauro Panteghini^{1

2}

Affiliations

¹ Department of Biomedical and Clinical Sciences and Research Centre for Metrological Traceability in Laboratory Medicine (CIRME), Università degli Studi di Milano, Milan, Italy.
² Department of Laboratory Medicine, ASST Fatebenefratelli-Sacco, Milan, Italy.

PMID: 34152694
DOI: 10.1111/liv.14987

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Laboratories*
Non-alcoholic Fatty Liver Disease* / diagnosis
Non-alcoholic Fatty Liver Disease* / therapy